Marketa Bednarikova

6PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 24, 2026
Prognostic Impact of PD-L1 Expression in Ovarian Cancer: Analysis of a Real-World Cohort Treated With Primary Platinum-Based Chemotherapy.

|Oct 27, 2025
SMARCA4-deficient dedifferentiated ovarian carcinoma with rapid progression during adjuvant platinum-based chemotherapy: a case report and implications for molecular-driven treatment strategies.

Markéta Bednarˇíková, Jitka Hausnerová, Petra Pokorná

|Aug 04, 2025
Real-World Data From a Molecular Tumor Board-Assisted Cancer Care From a Single Center in The Czech Republic: Is Precision Oncology an Accessible Option, or a Privilege for a Minority of Patients?

Michal Eid, Markéta Bednaříková, Jakub Vlažný

|Sep 06, 2024
Surgical treatment of recurrent gynecological malignancies.

Tomáš Crha, Vít Weinberger, Luboš Minář

|Feb 28, 2024
Ultrasound finding of endometrial polyp and factors increasing risk of malignancy.

Michaela Koblížková, Petra Bretová, Michal Felsinger

|May 28, 2022
Can Schlafen 11 Help to Stratify Ovarian Cancer Patients Treated with DNA-Damaging Agents?

Marketa Bednarikova, Jitka Hausnerova, Lucie Ehrlichova

Pageof 1

Frequent Collaborators

4 joint publications

Vít Weinberger

3 joint publications

Lubos Minar

2 joint publications

Jitka Hausnerova

2 joint publications

Michal Felsinger